Get it on Google Play

Sarepta Therapeutics (SRPT) Eteplirsen Gains Coverage at Aetna

November 21, 2016 10:21 AM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) on watch as Aetna (NYSE: AET) provides coverage for eteplirsen. LINK



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA

Add Your Comment